Singapore markets closed

Cidara Therapeutics, Inc. (CDTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
12.51-0.17 (-1.34%)
At close: 04:00PM EDT
12.00 -0.51 (-4.08%)
After hours: 06:44PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
63,905
63,905
64,448
49,572
12,067
Cost of revenue
1,523
1,523
0
-
-
Gross profit
62,382
62,382
64,448
-
-
Operating expenses
Research development
68,532
68,532
77,405
73,087
68,017
Selling general and administrative
18,333
18,333
20,546
18,740
15,899
Total operating expenses
86,865
86,865
97,951
91,827
83,916
Operating income or loss
-24,483
-24,483
-33,503
-42,255
-71,849
Income before tax
-22,488
-22,488
-33,312
-42,467
-72,111
Income tax expense
443
443
272
0
0
Income from continuing operations
-22,931
-22,931
-33,584
-42,467
-72,111
Net income
-22,931
-22,931
-33,584
-42,467
-72,111
Net income available to common shareholders
-22,931
-22,931
-33,584
-42,467
-74,873
Basic EPS
-0.39
-
-8.60
-16.20
-36.00
Diluted EPS
-0.39
-
-8.60
-16.20
-36.00
Basic average shares
82,772
-
3,493
2,623
2,078
Diluted average shares
82,772
-
3,493
2,623
2,078